P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population. (15th March 2017) - Di Mario, F.; Panozzo, M.P.; Baldassarre, G.; Antico, A.; Tursi, A.; Brandimarte, G.; Scarpignato, C.; Tomba, F.; Franceschi, M.